(19)
(11) EP 1 252 161 A1

(12)

(43) Date of publication:
30.10.2002 Bulletin 2002/44

(21) Application number: 01903486.7

(22) Date of filing: 02.02.2001
(51) International Patent Classification (IPC)7C07D 471/04, A61K 31/47
// (C07D471/04, 221:00), C07D209:00
(86) International application number:
PCT/US0103/430
(87) International publication number:
WO 0105/7039 (09.08.2001 Gazette 2001/32)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.02.2000 US 497379

(71) Applicant: Wyeth
Madison, New Jersey 07940-0874 (US)

(72) Inventors:
  • KELLY, Michael, Gerard
    Thousand Oaks, CA 91360 (US)
  • KANG, Young, Hee
    Robbinsville, NJ 08691 (US)

(74) Representative: Wileman, David Francis Dr. 
Wyeth Pharmaceuticals,Huntercombe Lane South,Taplow
Maidenhead,Berkshire SL6 OPH
Maidenhead,Berkshire SL6 OPH (GB)

   


(54) PYRROLO-ISOQUINOLINE AND TETRAHYDROPYRROLO-ISOQUINOLINE DERIVATIVES AND THEIR USE AS MEDIATORS OF THE 5-HT7 RECEPTOR